Health Trials

Transgender In Transition

ConditionGender Incongruence
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitätsklinikum Hamburg-Eppendorf

About this trial

Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.

Eligibility criteria

Qualifiers

diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)

written informed consent following adequate oral and written Information

before gender-affirming hormonal treatment

Disqualifiers

pregnancy or breast-feeding

Trial design

Treatments tested in this trial

  • Online surveys

Treatment groups

750 Participants
are divided into 1 treatment group

Locations

5
Germany
Universitätsklinikum Frankfurt60590, Frankfurt am MainHesse, Germany
University Medical Center Hamburg-Eppendorf20246, Hamburg Germany
Medical Center of the Ludwig-Maximilians-University of Munich Munich Germany
Switzerland
Universitätsspital Basel4031, Basel Switzerland

Sponsors and collaborators

Universitätsklinikum Hamburg-Eppendorf

Lead sponsor

Source ClinicalTrials.gov